Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study

Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3186. Online ahead of print.

Alwin Tubben^{1

2}, Hendrea S A Tingen^{2

3}, Niek H J Prakken⁴, Vanessa P M van Empel⁵, Thomas M Gorter¹, Laura M G Meems¹, Olivier C Manintveld⁶, Michiel Rienstra¹, Robert G Tieleman^{1

7}, Andor W J M Glaudemans³, Dirk J van Veldhuisen¹, Riemer H J A Slart^{2

3}, Hans L A Nienhuis^{2

8}, Peter van der Meer^{1

2}

¹ Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
² Amyloidosis Centre of Expertise, University Medical Centre Groningen, Groningen, The Netherlands.
³ Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, Groningen, The Netherlands.
⁴ Department of Radiology, University Medical Centre Groningen, Groningen, The Netherlands.
⁵ Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Medical University Centre Maastricht, Maastricht, The Netherlands.
⁶ Department of Cardiology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.
⁷ Department of Cardiology, Martini Hospital, Groningen, The Netherlands.
⁸ Department of Internal Medicine, University Medical Centre Groningen, Groningen, The Netherlands.

No abstract available

Grants and funding